Analysis of C-850T and G-308A polymorphisms of the tumor necrosis factor-α gene in Maya-Mestizo women with preeclampsia

Hypertension in Pregnancy

Volumn 26, Issue 3, 2007, Pages 283-291

  Canto Cetina, Thelma ^a   Canizales Quinteros, Samuel ^b   De La Chesnaye, Elsa ^c   Coral Vázquez, Ramón ^d   Méndez, Juan Pablo ^c   Canto, Patricia ^c  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

C 850T polymorphism; G 308A polymorphism; Maya Mestizo women; Preeclampsia; Promoter of the TNF

Indexed keywords

ADULT; ALLELE; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREECLAMPSIA; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; TUMOR NECROSIS FACTOR ALPHA GENE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MEXICO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548069161     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701372732     Document Type: Article

References (29)

1. López-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 2001; 34:1227-1235.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.
3. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
4. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, Bennett WA. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181:915-920.
5. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149:323-329.
6. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86:2505-2512.
7. Visser W, Beckmann I, Knook MA, Wallenburg HC. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand 2002; 81:713-719.
8. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22:396-402.
9. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997; 94:3195-3199.
10. Galbraith GM, Steed RB, Sanders JJ, Pandey JP. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol 1998; 69:428-433.
11. Maurer M, Kruse N, Giess R, Toyka KV, Rieckmann P. Genetic variation at position ?1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 2000; 104:98-100.
12. Pessi T, Karjalainen J, Hulkkonen J, Nieminen MM, Hurme M. A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 2003; 40:e66.
13. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104:154-159.
14. Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB. Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol 2005; 193:209-215.
15. Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M. Tumour necrosis factor-? gene haplotype is associated with pre-eclampsia. Mol Hum Reprod 2005; 11:437-440.
16. Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension. Chin Med J 2006; 119:719-724.
17. Dizon-Townson DS, Major H, Ward K. A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia. J Reprod Immunol 1998;38:55-61.
18. Lachmeijer AM, Crusius JB, Pals G, Dekker GA, Arngrimsson R, ten Kate LP. Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia. Obstet Gynecol 2001; 98:612-619.
19. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714.
20. Heiskanen J, Romppanen EL, Hiltunen M, Iivonen S, Mannermaa A, Punnonen K, Heinonen S. Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia. J Assist Reprod Genet 2002; 19:220-223.
21. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
22. Sambrook J, Russell D. Preparation and analysis of eukaryotic genomic DNA. In: Nolan C, ed. Molecular Cloning: A Laboratory Manual. 3th ed. New York: Cold Spring Harbor Laboratory Press, 2001:6.1-6.31.
23. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46:1468-1472.
24. Kato T, Honda M, Kuwata S, Juji T, Kunugi H, Nanko S, Fukuda M, Honda Y. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy. Am J Med Genet 1999; 88:301-314.
25. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 2:921-927.
26. Duran N, Couoh J. Epidemilogía de la preeclampsia-eclampsia de una muestra en Yucatán. Ginec Obstet Mex 1999; 67:571-577.
27. Pértegas Díaz S, Pita Fernández S. Unidad de Epidemiología Clínica y Bioestadística. Complexo Hospitalario-Universitario Juan Canalejo. A Coruña (España) Cad Aten Primaria 2003; 10:59-63.
28. Hotamisligil GS. The role of TNF alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245:621-625.
29. Lisker R, Ramirez R, Briceño RP, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 1990; 62:791-801.